. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: J R Stat Soc Series B Stat Methodol. 2016 Sep 2;79(4):1165–1185. doi: 10.1111/rssb.12201

Table 6.

Estimation results for the ACTG175 data.

t	Method	Intercept	Karnof	CD40	Age	S̃(t; η̃_opt)	CI₁	CI₀
400	I	−0.303	−0.340	0.024	0.890	0.965 (0.008)	(−0.002, 0.023)	(−0.003, 0.044)
	A	−0.729	−0.240	0.018	0.640	0.965 (0.008)	(−0.002, 0.022)	(−0.003, 0.043)
600	I	0.975	−0.082	0.001	0.206	0.923 (0.012)	(0.000, 0.045)	(−0.006, 0.052)
	A	0.909	−0.137	0.000	0.392	0.922 (0.012)	(0.000, 0.043)	(−0.009, 0.052)
800	I	0.871	−0.133	−0.010	0.473	0.887 (0.014)	(0.008, 0.058)	(−0.002, 0.069)
	A	0.874	−0.131	−0.009	0.469	0.886 (0.014)	(0.006, 0.057)	(−0.003, 0.068)
1000	I	−0.210	−0.185	−0.035	0.959	0.824 (0.017)	(0.004, 0.060)	(−0.006, 0.081)
	A	0.001	−0.187	−0.037	0.982	0.823 (0.017)	(0.002, 0.059)	(−0.007, 0.080)

^†

I denotes the S-IPSWKME and A denotes the S-AIPSWKME; the numbers in the parenthesis are the estimated standard errors; CI₁ and CI₀ denote the 95% confidence intervals for the difference of the value functions obtained under the estimated optimal treatment regime and the simple treatment regime assigning all to treatment 1 and 0, respectively.